Crossmark

Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation

Published Online: 2022-03-04

Published Print: 2022-12

Authors

Guan, Zhenfeng

Sun, Yi

Mu, Liang

Jiang, Yazhuo

Fan, Jinhai http://orcid.org/0000-0002-3391-8729
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81572520)

Shaanxi Provincial People's Hospital Incubation Fund Project (2018YXQ-03)
License Information

Text and Data Mining valid from 2022-03-04

Version of Record valid from 2022-03-04
More Information

Article History

Received: 12 October 2021

Accepted: 9 February 2022

First Online: 4 March 2022

Declarations

:

: The present study was approved by the Ethics Committee of Xi’an Jiaotong University and all patients involved in the present investigation had signed informed consent forms.

: Not applicable.

: The authors declare that they have no competing interests

Document is current